How can I find business partners and be in the know on industry intelligence?

    SOCMA’s commercial network helps you find the right connections to develop partnerships with contract manufacturers and customers. We are your bridge to finding suppliers and customers through our lead sheet services, and we are your source of intelligence for end-market insights and product applications. Our ChemSectors network provides the industry intelligence to make key business growth decisions.

    grow your business

    What resources will help me strengthen my operations, train my employees and improve safety?

    Our compliance and stewardship programs promote and guide the implementation of safe, sustainable and environmentally responsible operations across the supply chain.

    discover your resources

    Where can I get intel on the latest regulations and policy specifically impacting specialties?

    We are a powerful industry advocate. Our regulatory and legislative programs ensure you are always at the forefront of any issues or policies that may impact the way you do specialty chemistry.

    find policy solutions

    IN THE NEWS

    August 20, 2019

    GRACE MATTHEWS ADVISES RITUS CORPORATION AND VANSEAL CORPORATION ON SALE TO BLUE POINT CAPITAL PARTNERS

    Grace Matthews, Inc. and the shareholders of Ritus Corporation, including its subsidiary Classic Molding Company, and Vanseal Corporation (collectively, VRC Holdings Inc., or “VRC”) are pleased to announce the sale of VRC to Blue Point Capital Partners (“Blue Point”). VRC will continue to be led by the current management team, including President Tom Gebhardt. Financial terms of the transaction were not disclosed.
    Read more
    July 24, 2019

    Lonza on Track to Deliver Full-Year 2019 Results

    Lonza reported continued positive momentum in its core healthcare businesses in the first six months of 2019. This has driven 6.4% sales and 7.7% CORE EBITDA growth for the group, resulting in a CORE EBITDA margin of 27.8%. Based on H1 2019 results, Lonza confirms the Full-Year 2019 outlook of mid-to-high single-digit sales growth and a sustained CORE EBITDA margin.
    Read more
    July 24, 2019

    Lonza Expands Bioconjugation Facility

    Lonza today announced the start of expansion to its bioconjugation facility in Visp, Switzerland together with the successful commercial approval of a third antibody-drug-conjugate (ADC) produced at the site.
    Read more

    UPCOMING EVENTS